Nuvasive Inc (NUVA) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access NUVA quarterly Cash Flow →
Changes in quarterly cash flow trends offer perspective on how Nuvasive Inc funds operations, investments, and shareholder returns.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2022)
12 Months
(Dec 31 2021) (Dec 31 2020) (Dec 31 2019) (Dec 31 2018)
Operating Activities
Income40.41
Depreciation & amortization147.03
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability-14.71
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-22.65
Research and Development in Process0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation28.60
Income (Loss) from Equity Method Investments0.00
Foreign Currency Transaction Gain (Loss), before Tax, Total18.85
Impairment Of Intangible Assets Excluding Goodwill-
Embedded Derivative Gain Loss On Embedded Derivative Net-
Lease Abandonment Charge Reversal-
Accretion Of Contingent Consideration-
Goodwill And Intangible Asset Impairment-
Reserve On Current Asset-0.70
Increase Decrease In Contingent Consideration Liabilities-
Impairment Of Investments-
Increase Decrease In Fair Value Of Contingent Consideration-
Amortization Of Non Cash Interest7.89
Income taxes-10.95
Gain (Loss) on Investments2.84
Accounts Receivable-34.83
Increase (Decrease) in Accounts Payable and Accrued Liabilities-9.87
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets4.62
Other Working Capital0.00
Other Noncash Income (Expense)12.61
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities169.12
Investing Activities
Capital Expenditures-139.43
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Payments to Acquire Available-for-sale Securities, Debt0.00
Real Estate Investments0.00
Payments To Acquire Restricted Cash And Investments-
Payment Of Contingent Consideration For Simplify Medical-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired-0.75
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities-0.70
Other Net-14.32
Discontinued operations0.00
Net Cash Flow from Investing Activities-155.19
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.14
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-249.47
Extinguishment Of Debt Amount-
Payment Of Contingent Consideration-6.84
Payments Upon Settlement Of Senior Convertible Notes-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents247.59
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-8.59
Effect of exchange rate on cash flow-2.76
Discontinued operations0.00
Free Cash Flow29.69
Total Cash Flow2.57
4 historic quarters locked

Sign in to unlock the full Nuvasive Inc cash flow history.

About Nuvasive Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001142596-23-000035

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document





                    
Get the full CSIMarket dataset: Subscribe API License